Tratamiento de la endometriosis con 5mg o 25mg diarios de mifepristona durante 6 meses. Ensayo clínico aleatorizado, doble ciego

Josep Lluís Carbonell Esteve, Orlando Perera Boza, Ana María Riverón Cobo, J. González, Giuseppe Tomasi
In: Progresos de Obstetricia y Ginecología · 2011 · vol. 55(2) , pp. 51–59 · doi:10.1016/j.pog.2011.09.005 · W2092266262
RCT OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This randomized, double-blind study found that 5 mg and 25 mg daily doses of mifepristone significantly reduced dysmenorrhea and dyspareunia in women with endometriosis over six months.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Evaluar la eficacia y seguridad de 5 y 25 mg de mifepristona en el tratamiento de la endometriosis. Ensayo clínico aleatorizado, doble ciego. Hospital Eusebio Hernández, La Habana, Cuba. Veintiséis mujeres con diagnóstico laparoscópico de endometriosis. Grupo I: una tableta oral diaria de 25 mg de mifepristona, o grupo II: una tableta oral diaria de 5 mg de mifepristona, durante 6 meses. Se realizó laparoscopia y biopsia endometrial pre y postratamiento. Reducción de la intensidad de la dismenorrea medida por una escala visual análoga. En ambos grupos las disminuciones de la intensidad de la dismenorrea y la dispareunia fueron muy significativas comparadas con los valores iniciales. Todas las mujeres estaban en amenorrea a los 45 días de tratamiento. La mifepristona, en dosis de 25 o 5 mg, podría ser una alternativa para el tratamiento de la endometriosis. To evaluate the safety and efficacy of 5 mg and 25 mg doses of mifepristone for the treatment of endometriosis. Randomized double-blind study. Eusebio Hernández Hospital, Havana, Cuba. Twenty-six women laparoscopically diagnosed with endometriosis were included. Group I received one tablet of 25 mg mifepristone daily and group II received one tablet of 5 mg mifepristone daily for 6 months. Laparoscopy and endometrial biopsy were performed before and after treatment. Reduction in the intensity of dysmenorrhea measured by a visual analogue scale. In both groups reductions in the intensity of dysmenorrhea and dyspareunia were highly significant compared with initial values (P <.001). All the women were amenorrheic after 45 days of treatment. At doses of 5 mg or 25 mg, mifepristone could be an alternative for the treatment of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosisdysmenorrheadyspareunia

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (47)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-10-12T06:33:14.382917+00:00
License: CC0 · commercial use OK